X4 Pharmaceuticals, Inc. (XFOR) Shareholders’ equity 2018–2025
X4 Pharmaceuticals, Inc. (XFOR) shareholders’ equity at each fiscal year-end, per SEC filings.
$186.3MFY2025 · since FY2018: -$77.1M → $186.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $186.3M | +741.1% |
| FY2024 | $22.1M | -56.7% |
| FY2023 | $51.1M | -31.0% |
| FY2022 | $74.1M | +15.0% |
| FY2021 | $64.4M | -11.5% |
| FY2020 | $72.8M | -43.7% |
| FY2019 | $129.2M | +267.6% |
| FY2018 | -$77.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice